Updated label allows Neuraceq to be used in selecting patients for amyloid-targeting therapies and includes the use of ...

In a nutshell Scientists used magnetic brain stimulation to restore damaged connections in mice with Alzheimer’s-like ...

People with dementia were slower to notice the triangle compared to people who did not have the condition. Their data ...

What exactly is Alzheimer’s disease, and how common is it? A: Alzheimer’s disease is a neurodegenerative disease that causes dementia. It is caused in part by the accumulation of abnormally folded ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Researchers have developed a blood test that detects Alzheimer's biomarkers at single-molecule levels, enabling earlier, ...

Life Molecular Imaging, Ltd. (LMI) announced that the U.S. Food and Drug Administration (FDA) has approved updated labeling for Neuraceq® (florbetaben F18 injection), expanding its indication for ...

New research reveals that Alzheimer's disease may impair nerve function not by reducing myelin, but by altering the proteins ...

According to the Alzheimer’s Association, more than 120,000 Missourians are living with the disease. But a newly approved ...

New immunotherapy drugs offer some hope in the fight against Alzheimer's disease but they're too pricey for the NHS ...